Evidence map›Paper›PMID 35186083›Full record

ArticleAdvances in virology2022

Antiretroviral (ARV) Drug Resistance and HIV-1 Subtypes among Injecting Drug Users in the Coastal Region of Kenya.

Gabriel O Ng'ong'a, George Ayodo, Fanuel Kawaka, Veronicah Knight, Musa Ngayo, Raphael M Lwembe

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gabriel O Ng'ong'aDepartment of Public Health, Jaramogi Oginga Odinga University of Science and Technology (JOOUST), P.O. Box 210-40601, Bondo, Kenya.
George AyodoDepartment of Public Health, Jaramogi Oginga Odinga University of Science and Technology (JOOUST), P.O. Box 210-40601, Bondo, Kenya.
Fanuel KawakaCenter for Viral Research, Kenya Medical Research Institute (KEMRI), P.O. Box 54840-00200, Nairobi, Kenya.ORCID https://orcid.org/0000-0002-3922-551X
Veronicah KnightDepartment of Biological Sciences, Jaramogi Oginga Odinga University of Science and Technology (JOOUST), P.O. Box 210 - 40601, Bondo, Kenya.
Musa NgayoDepartment of Biological Sciences, Jaramogi Oginga Odinga University of Science and Technology (JOOUST), P.O. Box 210 - 40601, Bondo, Kenya.
Raphael M LwembeDepartment of Biological Sciences, Jaramogi Oginga Odinga University of Science and Technology (JOOUST), P.O. Box 210 - 40601, Bondo, Kenya.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HIV-1 genetic diversity results into the development of widespread drug-resistant mutations (DRMs) for the first-line retroviral therapy. Nevertheless, few studies have investigated the relationship between DRMs and HIV-1 subtypes among HIV-positive injecting drug users (IDUs). This study therefore determined the association between HIV-1 genotypes and DRMs among the 200 IDUs. Stanford HIV Drug Resistance Database was used to interpret DRMs. The five HIV-1 genotypes circulating among the IDUs were A

Identifiers

PMID35186083
PMCPMC8853818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.